Sharma Himanshu, Aqil Mohammed, Imam Faisal, Alam Mohammad S, Kapur Prem, Pillai Krishna K
Ranbaxy Research Laboratories. Gurgaon, Haryana ( India ).
Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University . New Delhi ( India ).
Pharm Pract (Granada). 2007 Jan;5(1):46-9. doi: 10.4321/s1886-36552007000100008.
The aim of the present study was to monitor adverse drug reactions (ADRs) in the Medicine out patient department (OPD) of a University Teaching Hospital.
A prospective evaluation of the ADRs reported in the Department of Medicine of our University Teaching Hospital over a period of 4-months was conducted.
During the study period, a total of 600 patients visited the Medicine OPD and 122 ADRs were reported. Out of 122 reports that were identified, a higher percentage of ADRs in males (52.4%) was observed as compared to females (47.5%). Of the 122 ADRs, 50 were found to be mild (41.0%), 49 moderate (40.2%), and 23 severe (18.2%). A total of 71 (58.0%) ADRs were observed in patients receiving 4 or more medications concurrently. Conversely 46 (37.7%) ADRs were detected in patients using 3 or less medicines. The largest number of reports were associated with antihypertensive therapy (39.3%), followed by antimicrobials (31.1%) and antidiabetics (10.7%). Amongst the organ systems affected, gastrointestinal ADRs constituted a major component (24.7%) followed by skin reactions (22.2%). On causality assessment, nearly 29.5% ADRs were considered as probable, 33.6% possible and 6.6% could not be categorised and were placed under unassessable.
The present work is the maiden pharmacovigilance study conducted at our university teaching hospital. The data presented here will be useful in future, long term and more extensive ADR monitoring in the hospital and in promotion of rational prescribing and drug use in the hospital.
本研究的目的是监测一所大学教学医院内科门诊的药物不良反应(ADR)。
对我校教学医院内科在4个月期间报告的ADR进行前瞻性评估。
在研究期间,共有600名患者前往内科门诊,报告了122例ADR。在122份已确认的报告中,观察到男性ADR的比例(52.4%)高于女性(47.5%)。在122例ADR中,50例为轻度(41.0%),49例为中度(40.2%),23例为重度(18.2%)。在同时接受4种或更多药物治疗的患者中,共观察到71例(58.0%)ADR。相反,在使用3种或更少药物的患者中检测到46例(37.7%)ADR。报告数量最多的与抗高血压治疗相关(39.3%),其次是抗菌药物(31.1%)和抗糖尿病药物(10.7%)。在受影响的器官系统中,胃肠道ADR占主要部分(24.7%),其次是皮肤反应(22.2%)。因果关系评估显示,近29.5%的ADR被认为是很可能的,33.6%是可能的,6.6%无法分类,被列为无法评估。
本研究是我校教学医院开展 的首次药物警戒研究。这里呈现的数据将有助于未来在医院进行长期、更广泛的ADR监测,以及促进医院合理用药和药物使用。